ASP ISOTOPES INC - ASPI to provide quarterly business update call on November 21, 2025 at 8:30 am EST

ASPI to provide quarterly business update call on November 21, 2025 at 8:30 am EST

ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO

("ASPI" or "the Company")


ASPI TO PROVIDE QUARTERLY BUSINESS UPDATE CALL ON NOVEMBER 21, 2025 AT 8:30 AM EST


WASHINGTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP
Isotopes" or the "Company"), an advanced materials company focused on developing technologies and
processes for the production of isotopes for multiple industries, today announced it will hold a quarterly
business update conference call and webcast on Friday, November 21, 2025 at 8:30 a.m. (Eastern
Time).

Conference Call Information

To participate in this event, please log on or dial in approximately 5 minutes before the beginning of the
call.

Webcast Link

https://events.q4inc.com/attendee/428149635

Participant Dial-In Details

Date: November 21, 2025
Time: 8:30 a.m. EST
Dial in:

  •   USA / International Toll: +1 .646.968.2525
  •   USA - Toll-Free: +1.888.596.4144
  •   Canada – Toronto: +1.647.495.7514
  •   Canada - Toll-Free: +1.888.596.4144

Conference ID: 5073116 and press #

Transcript will be released after the call on the ASPI website.

About ASP Isotopes Inc.

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development
of technology and processes to produce isotopes for use in multiple industries. The Company employs
proprietary technology, the Aerodynamic Separation Process ("ASP technology"). The Company's initial
focus is on producing and commercializing highly enriched isotopes for the healthcare and technology
industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum
Enrichment technology that the Company is developing. The Company has isotope enrichment facilities
in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass
(light isotopes).

There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and
Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging
healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy
applications. We believe the ASP technology (Aerodynamic Separation Process) is ideal for enriching
low and heavy atomic mass molecules. For more information, please visit www.aspisotopes.com.

Contacts

Jason Assad– Investor relations
Email: Jassad@aspisotopes.com


18 November 2025

Sponsor
Valeo Capital Proprietary Limited

Date: 18-11-2025 07:40:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.